Status:
COMPLETED
COVID-19 Among Healthcare Workers in Belgian Hospitals
Lead Sponsor:
Sciensano
Collaborating Sponsors:
Institute of Tropical Medicine, Belgium
Conditions:
SARS-CoV-2
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Due to the situation this study, originally planted until September 2020, was extended with 7 months until April 2021. This extension was approved by the ethical committee University hospital Ghent, B...
Eligibility Criteria
Inclusion
- Any permanent medical and paramedical staff working in the hospital who provided a signed informed consent to participate in the study.
- Participants must have a social security insurance (mandatory in Belgium).
- This study only include adults.
Exclusion
- Staff hired on a temporary (interim) basis will be excluded as follow-up over time will be compromised.
- Administrative staff or technical staff will also be excluded.
- HCW who were not active during the inclusion period will automatically be excluded.
Key Trial Info
Start Date :
April 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
850 Patients enrolled
Trial Details
Trial ID
NCT04373889
Start Date
April 22 2020
End Date
April 30 2021
Last Update
October 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sciensano
Brussels, Belgium, 1050